Basal-like breast cancer usually lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal Growth Factor Receptor 2 (HER-2), which is generally defined as triple negative breast cancer (TNBC). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.